CNS pipeline · person

Malik Slassi, PhD

Senior Vice President of Innovation at Mindset Pharma, with over 30 years of pharma and biotech R&D and management experience. Previously founder, President and CSO of Fluorinov Pharma, which was acquired by Trillium Therapeutics in 2016.

  • 1 company

Current roles

Appears with

People sharing a company with Malik.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.